Immune Pharmaceuticals, Inc.
(NASDAQ : IMNP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading IMNP News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.50%176.960.4%$170.90m
PRGOPerrigo Co. Plc
-0.03%73.996.4%$144.57m
VRXValeant Pharmaceuticals International, Inc.
-1.39%9.2514.2%$140.56m
ALRAlere Inc.
0.12%49.162.7%$137.07m
UTHRUnited Therapeutics Corporation
4.32%125.7013.9%$97.54m
JAZZJazz Pharmaceuticals Plc
-1.69%159.282.2%$89.92m
MDCOMedicines Company
1.52%49.3222.5%$75.86m
ENDPEndo International Plc
0.80%11.378.9%$73.90m
MNKMallinckrodt Plc
1.16%46.9216.8%$69.52m
HZNPHorizon Pharma plc
-0.71%15.387.6%$41.04m
ICLRICON Plc
1.59%84.494.1%$35.05m
ICPTIntercept Pharmaceuticals, Inc.
-0.78%112.3522.3%$34.59m
PRXLPAREXEL International Corporation
0.73%63.837.9%$33.77m
PCRXPacira Pharmaceuticals, Inc.
1.04%48.5510.9%$31.50m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.25%118.737.6%$28.29m

Company Profile

Immune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of targeted therapeutics, including mAbs nanotherapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. The company acquires, develops and commercialises prescription drug products. Immune Pharmaceuticals was founded by Daniel G. Teper and Jean Elie Kadouche in March, 1993 and is headquartered in New York, NY.